HCW Biologics (HCWB) vs Revelation Biosciences (REVB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
HCW Biologics is the larger company by market cap ($3.5 million vs $3.0 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HCWB | REVB |
|---|---|---|
| Share price | $1.58 | $0.7615 |
| Market cap | $3.52M | $3.03M |
| 1-day change | +3.01% | -2.40% |
| P/E ratio (TTM) | — | 0.17 |
| EPS (TTM) | $-19.84 | $4.60 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $27.57 | $5.96 |
| 52-week low | $1.50 | $0.75 |
| Distance from 52-week high | -94.28% | -87.22% |
| Analyst consensus | buy | none |
| Avg. price target upside | +2945.69% | +2230.93% |
| Average volume | 376.23K | 39.50K |
| Shares outstanding | 2.24M | 3.98M |
| Employees | 35 | 8 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About HCW Biologics
HCWB stock →HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States. Its lead products include HCW11-018b, a novel, tetra-valent T-Cell engager; HCW11-040, a multifunctional fusion molecule that is a combination of cytokines and pembrolizumab; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is in clinical trial in patients with alopecia areata diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 35 employees
About Revelation Biosciences
REVB stock →Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health.
Health Care · Biotechnology: Pharmaceutical Preparations · 8 employees
HCWB vs REVB FAQ
Which is bigger, HCW Biologics or Revelation Biosciences?
HCW Biologics (HCWB) is larger, with a market capitalization of $3.52M compared with $3.03M for Revelation Biosciences (REVB).
Are HCW Biologics and Revelation Biosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.